Innovative approaches in CNS clinical drug development: Quantitative systems pharmacology - 24/12/20
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Summary |
Clinical trials involving brain disorders are notoriously difficult to set up and run. Innovative ways to develop effective prevention and treatment strategies for central nervous system (CNS) diseases are urgently needed. New approaches that are likely to renew or at least modify the paradigms used so far have been recently proposed. Quantitative systems pharmacology (QSP) uses mathematical computerized models to characterize biological systems, disease processes and CNS drug pharmacology. Integrated experimental medicine should increase the probability and predictability of success while controlling clinical trials costs. Finally, the societal perspective and patient empowerment also offer additional approaches to demonstrate the benefit of a new drug in the CNS field.
Le texte complet de cet article est disponible en PDF.Keywords : Pharmacology, Central nervous system, Clinical trials, Experimental medicine, Brain modeling, Quantitative system pharmacology
Plan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?